SuspendedPHASE1, PHASE2NCT05036837

Infiltration of Medical Ozone for the Treatment of Medication-Related Osteonecrosis of the Jaws (MRONJ)

Studying Osteonecrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Palermo
Principal Investigator
Olga Di Fede, Professor
University of Palermo - Italy
Intervention
OZOPROMAF_SEQ1(drug)
Enrollment
50 enrolled
Eligibility
18-99 years · All sexes
Timeline
20182022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05036837 on ClinicalTrials.gov

Other trials for Osteonecrosis

Additional recruiting or active studies for the same condition.

See all trials for Osteonecrosis

← Back to all trials